Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

BIO 1211

Known as: BIO-1211 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Background and Purpose: Some functional limitations and economic burden of therapeutic antibodies indicated that introducing of… Expand
Is this relevant?
2008
2008
OBJECTIVE To determine the inhibitory effects of BIO-1211, a very late antigen-4 (vla-4) antagonist, on bronchoconstriction and… Expand
Is this relevant?
2004
2004
The very late antigen-4 (VLA-4), also known as integrin alpha4beta1, is expressed on monocytes, T- and B-lympohocytes, basophils… Expand
Is this relevant?
2003
2003
OBJECTIVE To study the effects of very late antigen(VLA) antagonist BIO-1211 on eosinophil chemotaxis, recruitment and mediator… Expand
Is this relevant?
2003
2003
Objective: To study the effects of very late antigen(VLA) antagonist BIO-1211 on eosinophil chemotaxis,recruitment and mediator… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
The leukocyte integrin very late antigen-4 ( α4β1, CD49d/CD29) is an adhesion receptor that plays an important role in allergic… Expand
Is this relevant?
2000
2000
  • G. Bolger
  • IDrugs : the investigational drugs journal
  • 2000
  • Corpus ID: 30706922
Biogen, in collaboration with Merck & Co, is developing late activator VLA-4 (alpha4beta1) integrin antagonists for the potential… Expand
Is this relevant?
2000
2000
The leukocyte integrin very late antigen-4 (alpha(4)beta(1), CD49d/CD29) is an adhesion receptor that plays an important role in… Expand
Is this relevant?
2000
2000
: Biogen, in collaboration with Merck & Co, is developing late activator VLA-4 (alpha4beta1) integrin antagonists for the… Expand
Is this relevant?
1999
1999
Integrin alpha4beta1 mediates leukocyte recruitment, activation, mediator release, and apoptosis inhibition, and it plays a… Expand
Is this relevant?